Search and analyze individual stocks with comprehensive metrics

Bdh Industries Ltd

BDHPharmaceuticals

Fundamental Score

...

Bdh Industries Ltd Share Price & Market Analysis

Current Market Price (CMP)
430.95
No change data available
Market Cap
213.46 (Cr)
Industry
Pharmaceuticals

Profitability Metrics

Poor

Return on Equity

14.16%
Good

Return on Capital Employed

17.82%
Excellent

Operating Profit Margin (5Y)

14.87%
Average

Dividend Yield

1.21%

Valuation Metrics

Excellent

Price to Earnings

21.89x

Market Capitalization

213.46 (Cr)

Industry P/E

31.77x

Growth Metrics

Poor

YoY Quarterly Profit Growth

8.71%
Good

YoY Quarterly Sales Growth

16.82%
Poor

Sales Growth (5Y)

2.26%
Poor

EPS Growth (5Y)

9.31%
Poor

Profit Growth (5Y)

9.31%

Financial Health

Excellent

Debt to Equity

0.00x
Excellent

Interest Coverage

221.33x
Good

Free Cash Flow (5Y)

21.38 (Cr)

Ownership Structure

Average

Promoter Holding

49.70%
Poor

FII Holding

0.28%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
49.70%
Promoter Holding
213.46 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of BDH across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Excellent ROCE Performance (17.82%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Attractive Valuation (P/E: 21.89 vs Industry: 31.77)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Strong Revenue Growth (16.82%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Strong Interest Coverage (221.33x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

3 factors identified

Limited Growth History (2.26% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.

Limited Institutional Interest (FII+DII: 0.28%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Loading Peer Comparison

Finding companies in the Pharmaceuticals sector...

Financial Statements

Comprehensive financial data for Bdh Industries Ltd

About BDH

Company Details

Symbol:BDH
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Market Information

Market Cap:213.46 (Cr)
P/E Ratio:21.89
Beta:N/A

Performance

52W High:N/A
52W Low:N/A
Dividend Yield:1.21%

BDH Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)14.16%
Return on Capital Employed17.82%
Operating Profit Margin (5Y)14.87%
Debt to Equity Ratio0.00
Interest Coverage Ratio221.33

Growth & Valuation

Sales Growth (5Y)2.26%
Profit Growth (5Y)9.31%
EPS Growth (5Y)9.31%
YoY Quarterly Profit Growth8.71%
YoY Quarterly Sales Growth16.82%

Frequently Asked Questions

What is the current price of BDH?

BDH is currently trading at ₹430.95 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of BDH shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.

What is the P/E ratio of BDH and what does it mean?

BDH has a P/E ratio of 21.89x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹22 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.

How is BDH performing according to Bull Run's analysis?

BDH has a Bull Run fundamental score of 53.8/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 14.16%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.

What sector and industry does BDH belong to?

BDH operates in the Pharmaceuticals industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Bdh Industries Ltd. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.

What is Return on Equity (ROE) and why is it important for BDH?

BDH has an ROE of 14.16%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Bdh Industries Ltd generates profits from shareholders' equity. An ROE of 14% means the company generates ₹14 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.

How is BDH's debt-to-equity ratio and what does it indicate?

BDH has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. This means the company has ₹0 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.

What is BDH's dividend yield and is it a good dividend stock?

BDH offers a dividend yield of 1.21%, which means you receive ₹1.21 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.

How has BDH grown over the past 5 years?

BDH has achieved 5-year growth rates of: Sales Growth 2.26%, Profit Growth 9.31%, and EPS Growth 9.31%. These growth metrics show the company's ability to expand its business and improve profitability over time. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.

What is the promoter holding in BDH and why does it matter?

Promoters hold 49.70% of BDH shares, with 0.00% of promoter shares pledged. This promoter holding level suggests balanced ownership between management and public shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.

How does BDH compare with its industry peers?

BDH trades at P/E 21.89x vs industry average 31.77x, with ROE of 14.16% and ROCE of 17.82%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether BDH is outperforming its competitive set in profitability, growth, and valuation metrics.

What is BDH's market capitalization and what category does it fall into?

BDH has a market capitalization of ₹213 crores, making it a Large-cap stock. Large-cap stocks offer stability and liquidity but typically slower growth. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.

What are the key financial ratios to consider for BDH?

Key ratios for BDH: ROE 14.16% (Good), ROCE 17.82%, P/E 21.89x, Debt-to-Equity 0.00, Interest Coverage 221.33x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.

How volatile is BDH stock and what is its beta?

BDH has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.

What is the 52-week high and low for BDH?

BDH has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹430.95, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.

What are the key risks associated with investing in BDH?

Key risks for BDH include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.00), and operational challenges. The stock has a Fundamental Score of 53.8/100, indicating moderate risk requiring careful monitoring. Sector-specific risks in Pharmaceuticals include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.

What is BDH's operating profit margin and how has it trended?

BDH has a 5-year average Operating Profit Margin (OPM) of 14.87%, which is good and shows decent operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.

How is BDH's quarterly performance in terms of sales and profit growth?

BDH's recent quarterly performance shows YoY Sales Growth of 16.82% and YoY Profit Growth of 8.71%. This shows decent growth momentum in the business. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.

What is the FII and DII holding pattern in BDH?

BDH has FII holding of 0.28% and DII holding of 0.00%, totaling 0.28% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.